Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

From a Failed Breakout to a Failed Breakdown

The historical action of the precious metals sector over the past few weeks has continued. The strong recovery in GDX, GDXJ, and Silver has potentially invalidated the technical breakdown that occurred during the crash. It appears to be a failed breakdown. Furthermor...
Jordan Roy-Byrne, CMT | March 30, 2020 |

Failed Breakouts Take a Heavy Toll on the Oil Bulls

The bulls certainly made a strong run yesterday but didn’t finish the day on a strong note in the least. That’s an understatement, actually. They’ve given up almost all of their gains, closing below the many important resistances...
Nadia Simmons | September 6, 2019 |

My two favourite stocks for generating income

In last week's DailyWealth, Steve Sjuggerud published compelling research suggesting the worst is past and there's another bubble coming. The Federal Reserve is the reason. We've never before seen recessions when the Federal Reserve is in "accommodating" mode and interest ra...
Tom Dyson | October 28, 2012 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

Crude Oil Fails At Critical Fibonacci Level

Crude Oil recently rallied up to the $63 level and failed. This level is a key Fibonacci price level based on our proprietary adaptive Fibonacci price modeling system. It represents a Fibonacci Long Trigger Level that would suggest that a new bullish price trend could setup if...
Chris Vermeulen | May 15, 2019 |

Gold has Good Chance Now to Break-Out

The more times a level is tested, the weaker it becomes and the more likely it is to break. Once again, Gold has rallied up to the wall of resistance in the $1350 to $1375 region. Gold has previously tested that wall a handful of times but failed to break through. This...
Jordan Roy-Byrne, CMT | June 12, 2019 |

Downside Risk in Precious Metals

Last week we noted that the risks in precious metals were primarily technical. Sentiment and technicals urge caution over the short-term. The net speculative position in Gold has remained high for months while the 21-day daily sentiment index (DSI) hit 81%. Since the s...
Jordan Roy-Byrne, CMT | February 7, 2020 |

Hedge fund disasters are hurting the gold price

The price of gold has been kept down by hedge fund redemptions. These redemptions will end in a week and after that a nasty hand that has been holding the price of gold down will be lifted. As we begin this New Year news is starting to trickle out demonstrating that hedge fu...
Mike Swanson | January 11, 2013 |

Bitcoin Setting Up For Another Drop

Last year just days before the big Bitcoin breakdown we notified everyone publicly to get ready for a swift drop from $6000 to $4000 which played out perfectly within a few days. Our cycle system and technical analysis skills combined can pack a powerful punch and this one of ...
Chris Vermeulen | May 8, 2019 |

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug ontheir research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account f...
Stockhouse Editorial | March 28, 2019 |
1 2 3 4 5 6 7 8 9 10 ...